Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Sachse

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 18, 2015
[Subcutaneous panniculitis-like T-cell lymphoma : Two case reports]G Wagner, Ch Rose, V Meyer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 30, 2016
[Cutaneous squamous cell carcinoma]U Leiter, R Gutzmer, M Alter, et al.
The British Journal of Dermatology|July 26, 2008
The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markersC-D Klemke, J Brade, S Weckesser, et al.
Pediatric Transplantation|September 6, 2013
Growing experience with mTOR inhibitors in pediatric solid organ transplantationR Ganschow, L Pape, E Sturm, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 26, 2020
[Cutaneous squamous cell carcinoma]U Leiter, R Gutzmer, M Alter, et al.
The British Journal of Dermatology|April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cellsM Felcht, M Heck, C Weiss, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2023
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)Katharina C Kähler, S Hüning, D Nashan, et al.
Journal of Cancer Research and Clinical Oncology|May 14, 2024
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspectiveKatharina C Kähler, Ralf Gutzmer, Yenny Angela, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 18, 2015
[Subcutaneous panniculitis-like T-cell lymphoma : Two case reports]G Wagner, Ch Rose, V Meyer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 30, 2016
[Cutaneous squamous cell carcinoma]U Leiter, R Gutzmer, M Alter, et al.
The British Journal of Dermatology|July 26, 2008
The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markersC-D Klemke, J Brade, S Weckesser, et al.
Pediatric Transplantation|September 6, 2013
Growing experience with mTOR inhibitors in pediatric solid organ transplantationR Ganschow, L Pape, E Sturm, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 26, 2020
[Cutaneous squamous cell carcinoma]U Leiter, R Gutzmer, M Alter, et al.
The British Journal of Dermatology|April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cellsM Felcht, M Heck, C Weiss, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2023
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)Katharina C Kähler, S Hüning, D Nashan, et al.
Journal of Cancer Research and Clinical Oncology|May 14, 2024
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspectiveKatharina C Kähler, Ralf Gutzmer, Yenny Angela, et al.
Pageof 3